Candid Health Secures $29M Series B to Boost Revenue Cycle Automation

Candid Health has secured $29 million in a Series B funding round led by 8VC, aimed at enhancing automation within the revenue cycle. This investment is significant as it positions Candid Health to expand its technological capabilities, offering innovative solutions for billing teams grappling with inefficiencies in claims processing and denial management.

The Deal

Candid Health's Series B round raised a total of $29 million, reportedly led by 8VC. The funding will be utilized to further develop their automation technologies that streamline revenue cycle processes. While the exact valuation of Candid Health following this funding round hasn't been disclosed, the investment indicates strong confidence from investors in the potential for automation to transform healthcare billing practices.

What It Means for RCM

Increased efficiency in claims processing could lead to reduced days in accounts receivable (AR) for providers.
The focus on automation may help lower denial rates, as more sophisticated tools can catch issues before claims submission.
This investment may shift the vendor landscape, pushing competitors to enhance their own automation offerings to keep pace.

Market Context

The healthcare revenue cycle management sector continues to attract significant investment, reflecting a broader trend towards automation and efficiency. With rising operational costs and increasing regulatory pressures, companies like Candid Health are poised to play a crucial role in redefining how billing and claims processes are managed. This funding round underscores the pressing need for innovative solutions that can help healthcare organizations navigate complex revenue cycles more effectively.

Published by RevCycleAI Research · May 22, 2026